1. T1 Meta-analysis of idiopathic pulmonary fibrosis genome-wide analyses identifies three novel genetic signals associated with disease susceptibility. (12th November 2019) Authors: Allen, RJ; Guillen-Guio, B; Oldham, JM; Ma, SF; Dressen, A; Paynton, ML; Kraven, LM; Obeidat, M; Li, X; Braybrooke, R; Fingerlin, TE; Hall, IP; Sayers, I; Tobin, MD; Maher, TM; Schwartz, DA; Yaspan, BL; Molyneaux, PL; Flores, C; Noth, I Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P10 Weight loss is a feature of progressive disease in idiopathic pulmonary fibrosis. (12th November 2019) Authors: Barth, S; Hogben, C; King, M; Vitri, B; Mann, J; George, P; Kokosi, M; Kouranos, V; Renzoni, E; Wells, AU; Chua, F; Maher, TM; Molyneaux, PL Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S86 Serum biomarkers in SSc-ILD: association with presence, severity and prognosis. (12th November 2019) Authors: Stock, CJW; Visca, D; DeLauretis, A; Daccord, C; Kokosi, M; Alfieri, V; Kouranos, V; Margaritopoulos, G; George, PM; Molyneaux, PL; Chua, F; Maher, TM; Ong, V; Abraham, DJ; Denton, CP; Wells, AU; Renzoni, EA Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. S69 Verification of genetic associations with scleroderma associated interstitial lung disease. (12th November 2019) Authors: Stock, CJW; DeLauretis, A; Visca, D; Daccord, C; Kokosi, M; Kouranos, V; Margaritopoulos, G; George, PM; Molyneaux, PL; Chua, F; Maher, TM; Abraham, DJ; Denton, CP; Ong, V; Wells, AU; Renzoni, EA Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P60 Temporally close presentation of primary lung cancer and idiopathic pulmonary fibrosis (IPF): an analysis of incident IPF cases from 2007 – 2018. (12th November 2019) Authors: Daniels, E; Kadwani, O; Molyneaux, P; George, P; Mann, J; Devaraj, A; Renzoni, E; Maher, TM; Kouranos, V; Kokosi, M; Kemp, S; Shah, P; Nicholson, AG; Desai, SR; Wells, AU; Chua, F Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P201 Rituximab as rescue therapy in interstitial lung disease refractory to conventional immunosuppression. (14th November 2013) Authors: Abdullah, RR; Ming, D; Keir, GJ; Maher, TM; Wells, AU; Renzoni, EA Journal: Thorax Issue: Volume 68(2013)Supplement 3 Page Start: A167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. S34 The effects of a novel formulation of inhaled cromolyn sodium (pa101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, controlled, phase 2 trial. (15th November 2017) Authors: Brring, SS; Wijsenbeek, MS; Agrawal, S; den Berg, JWK van; Stone, H; Maher, TM; Tutuncu, A; Morice, AH Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. M30 Effect of dose reductions and/or interruptions on the efficacy of nintedanib in patients with idiopathic pulmonary fibrosis (ipf): subgroup analysis of the inpulsis trials. (15th November 2017) Authors: Maher, TM; Inoue, Y; Case, AH; Sakamoto, W; Stowasser, S; Wuyts, WA Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. S57 Predictors of uptake of ambulatory oxygen on completion of the ambox trial, a study to assess effects of ambulatory oxygen on quality of life in patients with fibrotic interstitial lung disease. (15th November 2017) Authors: Mori, L; Canu, S; Visca, D; Tsipouri, V; Bonini, M; Pavitt, M; Fleming, S; Firouzi, A; Farquhar, M; Leung, E; Hogben, C; Lauretis, A De; Kokosi, M; George, PM; Molyneaux, PL; Brown, J; Rippon, N; Chetta, A; Russell, AM; Saunders, P Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. S56 The impact of azithromycin in idiopathic pulmonary fibrosis. (15th November 2017) Authors: Alzaher, O; Macaluso, C; Maritano, J; Chaube, R; Chua, F; Kokosi, M; Kouranos, V; Wells, AU; Maher, TM; George, PM; Renzoni, ER; Molyneaux, PL Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗